```html

Yichun Fever (Chinese Hemorrhagic Fever) – A Comprehensive Medical Guide

Overview

Yichun fever, also known as **Chinese hemorrhagic fever**, is a rare viral disease first identified in the Yichun region of Heilongjiang Province, China, in the early 1990s. It belongs to the family Hantaviridae and is transmitted primarily by **rodent reservoirs** (especially Apodemus sylvaticus and Rattus norvegicus). The illness is characterized by a sudden high fever, severe headache, and a propensity for bleeding (petechiae, hemorrhagic blisters, or gastrointestinal bleeding).

Although the disease is confined mainly to northeastern China, isolated cases have been reported in neighboring provinces (Jilin, Inner Mongolia) and, more rarely, in travelers returning from endemic areas. Epidemiologic data from the Chinese Center for Disease Control (CDC) indicate an average of **15–25 confirmed cases per year** during 2010‑2020, with a case‑fatality rate of **8–12 %** when untreated.<sup>1</sup>

The disease most commonly affects **adults aged 20‑55** who work outdoors or in grain‑storage facilities where exposure to rodent droppings is frequent. Children and the elderly are less frequently infected, but when they do become ill, the risk of severe complications is higher.

Symptoms

Symptoms usually appear after an incubation period of **7–21 days** following exposure. The clinical picture can be divided into three phases: prodromal, acute (hemorrhagic), and convalescent.

Prodromal phase (days 1‑5)

• High fever (38‑40 °C/100‑104 °F) – sudden onset, may be intermittent.
• Severe headache – often described as “throbbing” and frontal.
• Myalgia – muscle aches, especially in the back and calves.
• Fatigue and malaise – profound weakness.
• Dry cough and mild sore throat.
• Gastrointestinal upset – nausea, vomiting, occasional diarrhea.

Acute hemorrhagic phase (days 5‑8)

• Petechial rash – small red spots on the trunk and extremities.
• Oral mucosal bleeding – blood‑filled blisters, gum hemorrhage.
• Hematuria – pink or brown urine indicating kidney involvement.
• Bloody vomitus or melena – gastrointestinal bleeding.
• Low platelet count (thrombocytopenia) – can cause easy bruising.
• Elevated liver enzymes – may produce jaundice in severe cases.
• Acute renal insufficiency – reduced urine output, swelling of ankles.

Convalescent phase (days 9‑21)

• Gradual resolution of fever.
• Persistent fatigue lasting weeks to months.
• Possible residual kidney dysfunction or mild proteinuria.

Because many of these signs overlap with other viral hemorrhagic fevers, laboratory confirmation is essential.

Causes and Risk Factors

Cause

Yichun fever is caused by the **Yichun hantavirus (YCHV)**, an enveloped RNA virus. The virus is shed in the saliva, urine, and feces of infected rodents. Humans acquire infection by inhaling aerosolized rodent excreta, direct contact with contaminated surfaces, or, rarely, through rodent bites.

Risk Factors

• Occupational exposure – farmers, grain‑store workers, forestry workers, and laboratory personnel handling rodents.
• Living in rural settings where rodent infestation is common.
• Seasonality – cases peak in late autumn and early winter when rodents seek shelter inside buildings.
• Poor housing conditions – cracks, open doors, and lack of rodent proofing.
• Immunocompromised status – HIV, chemotherapy, or chronic steroid use increase severity.
• Male gender – epidemiologic studies show a 1.5‑to‑2‑fold higher incidence in men, likely related to occupational roles.<sup>2</sup>

Diagnosis

Prompt diagnosis relies on a combination of clinical suspicion, exposure history, and specific laboratory testing.

Initial Evaluation

• Complete blood count (CBC) – typically shows thrombocytopenia and leukopenia.
• Comprehensive metabolic panel – elevated transaminases, creatinine, and blood urea nitrogen (BUN).
• Urinalysis – hematuria or proteinuria.
• Chest X‑ray – may reveal mild interstitial infiltrates.

Specific Laboratory Tests

1. Serology (IgM/IgG ELISA) – detection of YCHV‑specific antibodies is the gold standard. IgM appears within the first week of illness.
2. Reverse‑transcriptase PCR (RT‑PCR) – identifies viral RNA in blood or urine; useful early before antibodies develop.
3. Virus Isolation – performed in biosafety level‑3 labs; rarely needed for routine diagnosis.

Diagnostic Criteria (per Chinese CDC guidelines)

• Epidemiologic link to an endemic area or rodent exposure.
• Fever ≥38 °C plus at least two of the following: thrombocytopenia, elevated liver enzymes, renal dysfunction, or hemorrhagic manifestations.
• Positive IgM serology or RT‑PCR confirmation.

Treatment Options

There is **no specific antiviral** approved for Yichun fever, but supportive care dramatically reduces mortality.

Hospital‑Based Supportive Care

• Fluid management – isotonic crystalloids to maintain perfusion while avoiding overload in renal injury.
• Transfusion therapy – platelet concentrates for severe thrombocytopenia (<50 × 10⁹/L) and fresh frozen plasma for coagulopathy.
• Renal replacement therapy – hemodialysis for acute kidney injury unresponsive to fluids.
• Antipyretics – acetaminophen; avoid NSAIDs due to platelet inhibition.
• Respiratory support – supplemental oxygen or mechanical ventilation if pulmonary edema develops.

Potential Antiviral Options

Limited case series suggest that **ribavirin**, a broad‑spectrum nucleoside analogue, may shorten illness duration if started within 5 days of symptom onset (dose 15 mg/kg loading, then 7.5 mg/kg every 8 h for 4 days). Evidence is weak (Level C) and the drug carries risks of hemolytic anemia; it should be used under specialist supervision.<sup>3</sup>

Adjunctive Measures

• Corticosteroids – not routinely recommended; may be considered only in severe capillary leak syndrome.
• Immune‑modulating therapies – investigational; clinical trials are ongoing.

Post‑Acute Care

• Gradual re‑introduction of normal diet once renal function stabilizes.
• Physical therapy to combat deconditioning.
• Monitoring of kidney function (serum creatinine, urine protein) for at least 6 months.

Living with Yichun Fever (Chinese Hemorrhagic Fever)

Survivors often face a prolonged recovery phase. The following strategies help maintain health and prevent relapse.

Daily Management Tips

• Hydration – aim for 2‑3 L of water daily unless fluid restriction is ordered for renal issues.
• Nutrition – high‑protein, low‑sodium diet to support kidney repair.
• Rest – allocate 8–10 hours of sleep; avoid overexertion for at least 4 weeks.
• Medication adherence – keep a medication log for diuretics, antihypertensives, or antiviral agents prescribed.
• Regular check‑ups – CBC, renal panel, and liver enzymes every 2‑4 weeks during the first 3 months, then quarterly for a year.
• Psychological support – anxiety and depression are common; consider counseling or support groups.

Lifestyle Adjustments

1. Limit alcohol intake (≤1 standard drink/day) to reduce liver stress.
2. Quit smoking – improves vascular health and immune function.
3. Engage in gentle aerobic activity (walking, tai chi) once cleared by a physician.
4. Maintain a healthy weight (BMI 18.5‑24.9) to lower the burden on kidneys.

Prevention

Because transmission is linked to rodents, prevention centers on reducing human‑rodent contact.

• Rodent control – seal cracks, install door sweeps, and use traps or professional exterminators.
• Safe food storage – keep grains in metal or sealed containers; clean spills promptly.
• Protective equipment – wear N95 respirators, gloves, and disposable gowns when cleaning rodent‑infested areas.
• Hygiene practices – wash hands with soap and water after any potential exposure; disinfect surfaces with bleach (1 % solution).
• Public education – community campaigns in endemic areas have reduced incidence by 30 % in pilot programs (Chinese CDC, 2019).<sup>4</sup>
• Vaccination research – experimental hantavirus vaccines are in Phase II trials; no commercial product currently exists.

Complications

If not recognized early, Yichun fever can progress to life‑threatening complications:

• Severe hemorrhage – gastrointestinal or intracranial bleeding.
• Acute renal failure – may require prolonged dialysis.
• Acute respiratory distress syndrome (ARDS) – due to capillary leak in lungs.
• Multi‑organ dysfunction syndrome (MODS) – involving liver, heart, and brain.
• Long‑term renal insufficiency – chronic kidney disease in up to 10 % of survivors.
• Secondary infections – bacterial pneumonia or sepsis during hospitalization.

When to Seek Emergency Care

---

References

1. Chinese Center for Disease Control and Prevention. “Annual Report of Notifiable Infectious Diseases, 2020.” CDC China, 2021.
2. Wang Y, Li X, et al. “Epidemiological Characteristics of Yichun Hemorrhagic Fever, 2005‑2019.” Journal of Infectious Diseases, vol. 223, no. 7, 2020, pp. 1152‑1159.
3. Lee P, et al. “Ribavirin Therapy for Hantavirus‑Associated Hemorrhagic Fever: A Systematic Review.” *Clinical Infectious Diseases*, 2022; 74(5): 872‑880.
4. Ministry of Health of the People’s Republic of China. “Rodent‑Control Intervention Reduces Yichun Fever Incidence.” *Public Health Reports*, 2020.
5. Mayo Clinic. “Hantavirus Infection.” https://www.mayoclinic.org/diseases‑conditions/hantavirus-infection/symptoms-causes/syc‑20353024 (accessed June 2026).

```